PharmaCytics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.48M
- Investors
-
5
PharmaCytics General Information
Description
Developer of a drug-conjugating technology designed to improve the lives of patients. The company's technology enhances medication transport through cellular membranes by exploiting intestinal transporter proteins as carriers for drug conjugates in which a transporter substrate is linked to a drug moiety, enabling pharmaceutical industry to enhance the impact of drug treatment.
Contact Information
Website
www.pharmacytics.comCorporate Office
- Transistorweg 5v
- Novio TechCampus
- 6534 AT Nijmegen
- Netherlands
Corporate Office
- Transistorweg 5v
- Novio TechCampus
- 6534 AT Nijmegen
- Netherlands
PharmaCytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 17-Feb-2020 | $1.48M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series 3) | Completed | Startup |
PharmaCytics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PharmaCytics Patents
PharmaCytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4359419-A1 | Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units | Pending | 21-Jun-2021 | ||
| US-20240299554-A1 | Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units | Pending | 21-Jun-2021 | ||
| WO-2022271018-A1 | Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units | Inactive | 21-Jun-2021 | ||
| CA-3086233-A1 | Method for improving the oral bioavailability of a drug | Pending | 21-Dec-2017 | ||
| EP-3728280-A1 | Method for improving the oral bioavailability of a drug | Active | 21-Dec-2017 | C07H15/26 |
PharmaCytics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PharmaCytics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovation for Health | Corporation | |||
| Rijksdienst voor Ondernemend Nederland | Government | |||
| Brabant Startup Fund | Venture Capital | Minority | ||
| Pharma Tide Invest | Venture Capital | Minority | ||
| RedMedtech Ventures | Lender/Debt Provider | Minority |
PharmaCytics FAQs
-
When was PharmaCytics founded?
PharmaCytics was founded in 2015.
-
Where is PharmaCytics headquartered?
PharmaCytics is headquartered in Nijmegen, Netherlands.
-
What is the size of PharmaCytics?
PharmaCytics has 6 total employees.
-
What industry is PharmaCytics in?
PharmaCytics’s primary industry is Drug Delivery.
-
Is PharmaCytics a private or public company?
PharmaCytics is a Private company.
-
What is PharmaCytics’s current revenue?
The current revenue for PharmaCytics is .
-
Who are PharmaCytics’s investors?
Innovation for Health, Rijksdienst voor Ondernemend Nederland, Brabant Startup Fund, Pharma Tide Invest, and RedMedtech Ventures have invested in PharmaCytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
